Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

A late-breaking study at ACC.22 showed differences in COVID-positive heart attack patients between 2020 and 2021. #ACC22 #ACC2022

VIDEO: Vaccines boosted survival among STEMI heart attack patients with COVID-19

Santiago Garcia, MD, lead author of the study and director of the structural heart program at The Christ Hospital in Cincinnati, Ohio, presented new data from the North American COVID-19 STEMI (NACMI) registry at ACC.22. Severity of heart attacks were reduced in vaccinated patients, with zero deaths in vaccinated patients in 2021.

What clinicians need to know about PCI, other revascularization techniques among women

The Society for Cardiovascular Angiography & Interventions has shared a new expert consensus statement that highlights sex-specific considerations associated with revascularization

money maze payment reimbursement

CMS finalizes 2022 Medicare Physician Fee Schedule—payments to cardiologists take a hit

Also, penalties for failing to comply with the Appropriate Use Criteria program have been delayed yet again. 

Thumbnail

Cardiologists urge CMS to reconsider MPFS changes that could ‘jeopardize the delivery of care’

The American College of Cardiology and Society for Cardiovascular Angiography (SCAI) and Interventions are just two of the medical societies concerned about this proposal. 

Thumbnail

Interventional cardiologists back prior authorization bill, call current policies ‘costly' and ‘time consuming’

The Society for Cardiovascular Angiography and Interventions is the latest industry organization to show its support of the new legislation. 

SCAI 2021: Medtronic pleased with 30-day data on Evolut TAVR systems

Researchers presented 30-day data at the SCAI 2021 Scientific Sessions, highlighting the "excellent" outcomes and the importance of constantly working to improve patient care. 

SCAI 2021: Harmony TPV could ‘fundamentally alter’ care for patients with congenital heart disease

Overall, one-year findings showed that there were no instances of mortality, endocarditis, major stent fractures or surgical intervention among patients who received the Harmony TPV.

Thumbnail

SCAI 2021: Robotic-assisted PCI associated with strong patient outcomes, a high technical success rate

The procedure's clinical success rate was 97.8%, researchers reported. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.